SCHEMBL7234580

SCHEMBL7234580

CCc1cc(-c2cccnc2)nn1-c1ccc(NCc2c(C)cccc2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.57
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MYC P01106 2/20 0.38
WDR5 P61964 2/20 0.38
USP8 P40818 1/20 0.38
LHCGR P22888 2/20 0.37
PTK2 Q05397 1/20 0.36
F2 P00734 1/20 0.35
PDE4B Q07343 1/20 0.35
CYP2D6 P10635 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7241965 0.90 EPHX2 (0.56) EPHX2MAPTKDM4EALDH1A1USP8
SCHEMBL7232939 0.85 EPHX2 (0.61) EPHX2CA12CA1CA2CA9
SCHEMBL7630672 0.81 HDAC1 (0.42) EPHX2MAPTF2
SCHEMBL7241783 0.80 PTGS2 (0.37) EPHX2MAPTKDM4EALDH1A1CYP2D6
SCHEMBL7243350 0.78 ALDH1A1 (0.46) EPHX2CA12CA1CA2CA9
SCHEMBL7235296 0.76 ALDH1A1 (0.45) EPHX2MAPTKDM4EALDH1A1USP8
SCHEMBL7242287 0.75 MAPT (0.45) EPHX2MAPTKDM4EALDH1A1USP8
SCHEMBL7243090 0.75 EPHX2 (0.42) EPHX2CA12CA1CA2CA9
SCHEMBL7238788 0.74 USP8 (0.65) EPHX2CA12CA1CA2CA9
SCHEMBL7234775 0.74 EPHX2 (0.64) EPHX2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506747-B1 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US claimed
JP-2002516909-A 2002-06-11 JP claimed
WO-1999062885-A1 SUBSTITUTED 1-(4-AMINOPHENYL)PYRAZOLES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-12-09 WO claimed
US-6506747-B1 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US disclosed
WO-1999062885-A1 SUBSTITUTED 1-(4-AMINOPHENYL)PYRAZOLES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-12-09 WO disclosed